Results 21 to 30 of about 698,293 (229)

Volumetric determination of apolipoprotein stoichiometry of circulating HDL subspecies1[S]

Journal of Lipid Research, 2013
Although HDL is inversely correlated with coronary heart disease, elevated HDL-cholesterol is not always protective. Additionally, HDL has biological functions that transcend any antiatherogenic role: shotgun proteomics show that HDL particles contain 84
Jere P. Segrest, Marian C. Cheung, Martin K. Jones   +2 more
doaj   +1 more source

Hereditary Renal Amyloidosis Associated With a Novel Apolipoprotein A-II Variant

Kidney International Reports, 2017
To the Editor: Systemic amyloidosis is characterized by the extracellular deposition of misfolded proteins as insoluble amyloid fibrils in various tissues.
T. Prokaeva, H. Akar, Brian H. Spencer, A. Havasi, Haili Cui, C. O'Hara, O. Gursky, J. Leszyk, Martin Steffen, Sabrina Browning, A. Rosenberg, L. Connors   +11 more
semanticscholar   +1 more source

Phospholipids mediated conversion of HDLs generates specific apoA-II pre-β mobility particles

Journal of Lipid Research, 2009
Apolipoproteins (apo)A-I and A-II are major proteins of human HDL. The cycling of apoA-I between lipid-poor and lipid-rich forms of HDL plays a key role in the transport of cholesterol by these particles.
Małgorzata Wróblewska, Barbara Kortas-Stempak, Andrzej Szutowicz, Tadeusz Badzio   +3 more
doaj   +1 more source

Analysis of high density lipoprotein apolipoproteins by capillary zone and capillary SDS gel electrophoresis

Journal of Lipid Research, 1998
We describe new methods for analyzing the apolipoproteins (apo) of the high density lipoproteins (HDL) of several species by two modes of capillary electrophoresis: size separation using a molecular sieving buffer, and capillary zone electrophoresis (CZE)
Joseph Stocks, M. Nazeem Nanjee, Norman E. Miller   +2 more
doaj   +1 more source

High postprandial triglyceridemia in patients with type 2 diabetes and microalbuminuria

Journal of Lipid Research, 2007
Microalbuminuria (MA) is an independent risk factor for atherosclerosis in patients with type 2 diabetes mellitus (T2DM). Postprandial lipemia is also associated with excess cardiovascular risk.
Nicholas Tentolouris, Andreas Stylianou, Evangelia Lourida, Despoina Perrea, Despoina Kyriaki, Eleni C. Papavasiliou, Alexandros D. Tselepis, Nicholas Katsilambros   +7 more
doaj   +1 more source

A comparison of two methods to investigate the metabolism of human apolipoproteins A-I and and A-II.

Journal of Lipid Research, 1978
Two methods are compared for measuring the kinetic parameters of apolipoprotein A-I and A-II metabolism in human plasma. In the first, high density lipoprotein apoproteins were radioiodinated in situ in the lipoprotein particle (endogenous apoprotein ...
J Shepherd, C J Packard, A M Gotto, Jr, O D Taunton   +3 more
doaj   +1 more source

Identification of disulfide-linked apolipoprotein species in human lipoproteins

Journal of Lipid Research, 1993
We wished to determine whether apolipoprotein C-IIToronto, a mutant form of apolipoprotein C-II that contains a C-terminal cysteine residue, exists as a monomeric species or as multiple disulfide-linked species in plasma lipoproteins.
PW Connelly, GF Maguire, C Vezina, RA Hegele, JA Little   +4 more
doaj   +1 more source

Apolipoprotein Profiles in Very Preterm and Term‐Born Preschool Children

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background Little is known about plasma apolipoprotein profiles in very preterm‐born and term‐born preschool children compared with the adult population.
Anna Posod, Raimund Pechlaner, Xiaoke Yin, Sean Anthony Burnap, Sophia Julia Kiechl, Johann Willeit, Joseph L. Witztum, Manuel Mayr, Stefan Kiechl, Ursula Kiechl‐Kohlendorfer   +9 more
doaj   +1 more source

Effects of peroxisome proliferator-activated receptor α/δ agonists on HDL-cholesterol in vervet monkeys

Journal of Lipid Research, 2005
The objective of this study was to demonstrate the efficacy of a novel peroxisome proliferator-activated receptor (PPAR) agonist and known PPARα and PPARδ agonists to increase HDL-cholesterol (HDL-C) in the St.
Jeanne M. Wallace, Margrit Schwarz, Peter Coward, Jonathan Houze, Janet K. Sawyer, Kathryn L. Kelley, Anne Chai, Lawrence L. Rudel   +7 more
doaj   +1 more source

Apolipoprotein A-II Influences Apolipoprotein E-Linked Cardiovascular Disease Risk in Women with High Levels of HDL Cholesterol and C-Reactive Protein

PLoS ONE, 2012
Background In a previous report by our group, high levels of apolipoprotein E (apoE) were demonstrated to be associated with risk of incident cardiovascular disease in women with high levels of C-reactive protein (CRP) in the setting of both low ...
J. Corsetti, S. Bakker, C. Sparks, R. Dullaart   +3 more
semanticscholar   +1 more source